Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Ryan R. Sun"'
Autor:
Misty L. Noble-Vranish, Shuxian Song, Kyle P. Morrison, Dominic M. Tran, Ryan R. Sun, Keith R. Loeb, George W. Keilman, Carol H. Miao
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 10, Iss , Pp 179-188 (2018)
We have achieved significant enhancement of gene delivery into livers of large animals using ultrasound (US)-targeted microbubble (MB) destruction methods. An infusion of pGL4 (encoding a luciferase reporter gene) plasmid DNA (pDNA) and MBs into a po
Externí odkaz:
https://doaj.org/article/411c2bb3bde8429ab04f2514882c96b9
Autor:
Kianna Cadogan, Yushi Wang, Lauren Burton, Andrew Fast, Ryan R. Sun, Chris Dutka, Darrel Drachenberg, Cole Kubay
Publikováno v:
Surgery. 170(1)
BACKGROUND There is growing interest in identifying trainees with surgical aptitude predictive of eventual technical proficiency. Musical tasks involve complex, cerebral activity, and ambidextrousity, which may have a positive impact on the acquisiti
Autor:
Dominic M. Tran, Carol H. Miao, Kyle P. Morrison, George W. Keilman, Keith R. Loeb, Shuxian Song, Misty L. Noble-Vranish, Ryan R. Sun
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 10, Iss, Pp 179-188 (2018)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
We have achieved significant enhancement of gene delivery into livers of large animals using ultrasound (US)-targeted microbubble (MB) destruction methods. An infusion of pGL4 (encoding a luciferase reporter gene) plasmid DNA (pDNA) and MBs into a po
Autor:
Savannah C. Partridge, Ryan R. Sun, Sheila Ganti, Cheng Liang Liu, Alanna Ruddell, Sara B. Kirschbaum
Publikováno v:
Journal of Magnetic Resonance Imaging. 42:145-152
Background To use high resolution MRI lymphography to characterize altered tumor-draining lymph node (TDLN) lymph drainage in response to growth of aggressive tumors. Methods Six mice bearing B16-F10 melanomas in one rear footpad were imaged by 3.0 T
Publikováno v:
Journal of Controlled Release. 182:111-120
Ultrasound (US)-mediated gene delivery has emerged as a promising non-viral method for safe and selective gene delivery. When enhanced by the cavitation of microbubbles (MBs), US exposure can induce sonoporation that transiently increases cell membra
Autor:
Carol H. Miao, Misty L. Noble, Shuxian Song, Ryan R. Sun, Christian S. Kuhr, Scott S. Graves, George W. Keilman, Kyle P. Morrison, Keith R. Loeb, Andrew Brayman, Marla Paun, Rainer F. Storb, Samuel S. Sun
Publikováno v:
Proceedings of Meetings on Acoustics.
Autor:
Carol H. Miao, Luping Fan, Colleen O'Kelly-Priddy, Robert M DiBlasi, Shuxian Song, Keith R. Loeb, Misty L. Noble, Ryan R. Sun
Publikováno v:
AIP Conference Proceedings.
Ultrasound (US) targeted microbubble (MB) destruction (UTMD) has been shown to be an effective method in delivering drugs and plasmid DNA (pDNA) into cells. We previously reported successful gene transfection of a reporter luciferase gene, pGL4, into
Autor:
Chamseddine S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yavuz BG; Department of Internal Medicine, University of Missouri, Columbia, MO, USA., Mohamed YI; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee SS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yao JC; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hu ZI; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., LaPelusa M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xiao L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sun R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Morris JS; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Hatia RI; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hassan M; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Duda DG; Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Diab M; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GA., Mohamed A; Division of Hematology and Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Nassar A; Department of Surgery, Emory University, Atlanta, GA, USA., Amin HM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Kaseb AO; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Journal of immunotherapy and precision oncology [J Immunother Precis Oncol] 2024 Nov 01; Vol. 7 (4), pp. 255-262. Date of Electronic Publication: 2024 Nov 01 (Print Publication: 2024).
Autor:
Yousef M; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Yousef A; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Chowdhury S; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Fanaeian MM; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Knafl M; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston., Peterson J; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Zeineddine M; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Alfaro K; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Zeineddine F; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Goldstein D; Syntropy Technologies LLC, Cambridge, Massachusetts., Hornstein N; Department of General Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Dasari A; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Huey R; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Johnson B; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Higbie V; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Bent A; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Kee B; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Lee M; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Morelli MP; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Morris VK; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Halperin D; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Overman MJ; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Parseghian C; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Vilar E; Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston., Wolff R; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Raghav KP; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., White MG; Department of Colon and Rectal Surgery, University of Texas MD Anderson Cancer Center, Houston., Uppal A; Department of Colon and Rectal Surgery, University of Texas MD Anderson Cancer Center, Houston., Sun R; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston., Wang W; Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston., Kopetz S; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Willis J; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston., Shen JP; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Nov 01; Vol. 10 (11), pp. 1519-1529.
Autor:
LaPelusa M; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA, mblapelusa@mdanderson.org., Chamseddine S; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tran Cao HS; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Xiao L; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hasanov E; The Ohio State University Comprehensive Cancer Center - The James, Columbus, Ohio, USA., Bhosale P; Department of Abdominal Imaging, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Amin HM; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mohamed YI; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gok Yavuz B; University of Missouri School of Medicine, Columbia, Missouri, USA., Sakr Y; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Xu L; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hu I; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lee SS; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sakamuri D; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jindal S; The Immunotherapy Platform, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nguyen V; Department of Pharmacy Clinical Programs, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Curran MA; Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sun R; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rashid A; Department of Anatomic Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Duda DG; Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Sharma P; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Qayyum A; Department of Imaging and Interventional Radiology, Moffitt Cancer Center, Tampa, Florida, USA., Kaseb AO; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Oncology [Oncology] 2024 Oct 18, pp. 1-8. Date of Electronic Publication: 2024 Oct 18.